货号 | AF-291-SP |
别名 | IBP1; IGF1; IGF-1; IGF1A; IGFI; IGF-I; IGF-IA; IGF-IB; insulin-like growth factor 1 (somatomedin C); insulin-like growth factor 1; insulin-like growth factor I; insulin-like growth factor IA; insulin-like growth factor IB; Mechano growth factor; MGF; Somatomedin A; Somatomedin C; somatomedin-C | 全称 | Insulin-like Growth Factor I |
反应种属 | Human |
应用 | Western Blot,Immunohistochemistry,Immunocytochemistry,Neutralization |
目标/特异性 | Detects human IGF-I in direct ELISAs and Western blots. In direct ELISAs, approximately 35% cross-reactivity with recombinant mouse IGF-I and recombinant rat IGF-1 is observed, and less than 1% cross-reactivity with recombinant human (rh) IGF-2 and rhIGF-L1 is observed. |
使用方法 | Western Blot: 0.1 µg/mL Immunohistochemistry: 5-15 µg/mL Immunocytochemistry: 5-15 µg/mL Neutralization: Measured by its ability to neutralize IGF‑I-induced proliferation in the MCF‑7 human breast cancer cell line. Karey, K.P. et al. (1988) Cancer Research 48:4083. The Neutralization Dose (ND50) is typically 3-12 µg/mL in the presence of 6 ng/mL Recombinant Human IGF‑I. |
来源 | Polyclonal Goat IgG |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 3479 (Human); 16000 (Mouse); 24482 (Rat) |
应用文献 | |
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. Peripheral blood aspirates overexpressing IGF-I via rAAV gene transfer undergo enhanced chondrogenic differentiation processes | |
纯化方式 | Antigen Affinity-purified |
免疫原 | E. coli-derived recombinant human IGF-I |
内毒素水平 | <0.10 EU per 1 μg of the antibody by the LAL method. |
生物活性 | Human |
标记 | Unconjugated |
溶解方法 | Reconstitute at 0.2 mg/mL in sterile PBS. |
背景 | IGF-I belongs to the family of insulin-like growth factors andcirculates in complex with IGF binding proteins. It is a potentmitogenic growth factor that binds the heteromeric type I and type IIIGF receptors. Essentially, all of the biological activities of IGF-Iare mediated by IGF-I R. |
运输条件 | Blue Ice |
存放说明 | 4℃ |
参考文献 |
|
IGF-I in MDA‑MB‑231 Human Cell Line. IGF-I was detected in immersion fixed MDA-MB-231 human breast cancer cell line using Goat Anti-Human IGF-I Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-291-NA) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (yellow; Catalog # NL001) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Cells on Coverslips. | |
Cell Proliferation Induced by IGF‑I and Neutralization by Human IGF‑I Antibody. Recombinant Human IGF‑I (Catalog # 291-G1) stimulates proliferation in the MCF‑7 human breast cancer cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IGF‑I (6 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IGF-I Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-291-NA). The ND50 is typically 3‑12 µg/mL. | |
IGF‑I in Human Placenta. IGF‑I was detected in immersion fixed paraffin-embedded sections of human placenta using Goat Anti-Human IGF‑I Antigen Affinity-purified Polyclonal Antibody (Catalog #AF-291-NA) at 5 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). Specific staining was localized to syncytiotrophoblasts. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections. |